论文部分内容阅读
三株口服液是济南三株药业有限公司的起家产品,也是迄今为止的看家产品。当初一万元买来的转让配方,如今已创造了上百亿元的销售收入。在三株进入市场的前前后后,与三株相类似的保健药品比较知名的就有十多个品牌,但没有一个产品像三株口服液一样在短短几年内创造出不可思议的销售奇迹。1994年三株口服液实现规模生产,销售收人首次超亿元。1995年销售收入23.5亿元。1996年销售收入80.6亿元。1997年三株的目标是保200亿,争260亿,冲刺300亿。分析三株的成功经验,我们可以发现至
Three oral liquids are the starting products of Jinan Sansei Pharmaceutical Co., Ltd. and are also the housekeeping products so far. The transfer formula that was originally bought for 10,000 yuan has now generated sales revenue of more than 10 billion yuan. Before and after the three plants entered the market, there were more than a dozen brands that were similar to the three similar health care products. However, none of the products produced an incredible sales miracle in just a few years like the three oral liquids. In 1994, three oral liquids achieved scale production, and sales revenue exceeded RMB 100 million for the first time. In 1995, sales revenue was 2.35 billion yuan. In 1996, sales revenue was 8.06 billion yuan. In 1997, the goal of the three strains was to maintain 20 billion yuan, compete for 26 billion yuan, and sprint 30 billion yuan. Analyzing the successful experience of the three strains, we can find